Related Experiment Videos
Adrenomedullin: a hypotensive hormone in man
J G Lainchbury1, G J Cooper, D H Coy
1Department of Cardioendocrinology, Christchurch Hospital, New Zealand.
Clinical Science (London, England : 1979)
|May 1, 1997
Summary
Adrenomedullin, a peptide hormone, lowers blood pressure in humans without affecting kidney function or sympathetic activity. Its effects on arterial pressure occur at lower doses than previously thought.
Area of Science:
- Cardiovascular Physiology
- Endocrinology
- Renal Physiology
Background:
- Adrenomedullin is a peptide hormone with diverse biological actions, including vasodilation and natriuresis.
- Previous studies suggest potential roles in cardiovascular and renal regulation.
- Its bioactivity in humans requires further investigation.
Purpose of the Study:
- To investigate the hemodynamic, hormonal, renal, and biochemical effects of two doses of human adrenomedullin in healthy male subjects.
- To determine the dose-response relationship and threshold for adrenomedullin's bioactivity in humans.
Main Methods:
- A placebo-controlled, randomized study involving eight healthy male subjects.
- Intravenous administration of human adrenomedullin at 2 and 8 ng min-1 kg-1.
- Monitoring of hemodynamic parameters, hormonal levels, renal function, and biochemical markers.
Main Results:
- Adrenomedullin significantly reduced mean, systolic, and diastolic arterial pressure.
- These reductions occurred without compensatory increases in sympathetic activity or renin release.
- Urine volume and electrolyte excretion remained unaffected by adrenomedullin administration.
Conclusions:
- The threshold for adrenomedullin's effect on arterial pressure in humans is lower than for renal or hormonal responses.
- Adrenomedullin's bioactivity is evident at plasma concentrations relevant to circulatory disorders.
- Adrenomedullin may play a significant role in pathophysiological conditions affecting circulation.